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ABSTRACT 
 
 
The SNP (rs11209026, Arg381Gln, R381Q) in the IL-23 receptor (IL23R) confers 
protection against multiple inflammatory diseases, representing one of the most significant 
human genetic polymorphisms in inflammatory diseases. We, therefore, investigated the 
association between IL-23 R R381Q gene polymorphism and asthma.  
This case-control study was performed on 209 patients, and 200 healthy controls. Using 
PCR-RFLP, the R381Q variant was screened in the IL-23R gene of the patients and 
controls.  
Serum IgE levels were measured using ELISA technique. Eosinophil absolute count was 
done with Sesmex cell counter. 
Our results indicated that the genotype and allele frequencies of the IL-23R R381Q 
polymorphism is significantly different between asthmatic patients and control subjects (p< 
0.001; odd ratio= 0.266; 95%, CI=0.118-0.604. Moreover, the asthmatic patients had higher 
eosinophil count and total serum IgE levels than controls as expected (p<0.001). 
The present study suggested that R381Q polymorphism in IL-23 receptor may be a 
predisposing allele for asthma. 
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INTRODUCTION 
 
Asthma is a chronic inflammatory disease of the 
airways. It is suggested that IL-17A and IL-17F (Th 17 
cytokines) recruit neutrophils into the airways and 
bronchi of animal models of asthma.
1,2
 IL-17A 
expression in the airways of asthmatic patients is 
correlated with the severity of asthma.
3-5
 IL-23 has 
been recognized as a new IL-12 family cytokine which 
consists of p19 and a p40 subunits.
6
 It is known that IL-
23 plays pathogenic roles in chronic inflammatory 
diseases such as inflammatory bowel diseases, arthritis, 
and psoriasis.
7,8
 Furthermore, IL-23 is vital for the 
differentiation, maintenance and effector functions of 
Th17 cells.
9
 that the role of IL-23/Th17 axis in the 
development of inflammatory diseases has been fully 
elucidated.
10-12
 In addition, IL-23 can cause 
eosinophilic inflammation in the airways.
13
 IL-23 
signals through IL-23R
14
 and IL-23R is located on the 
chromosome 1p31.
15
 
Polymorphisms in the IL-23R chain may affect IL-
23 responses. Recent studies have shown that a 
functional single-nucleotide polymorphism (SNP) 
(Arg381Gln;R381Q; rs11209026; 1142 G wild type A 
reduced function) in the IL-23R gene leads to 
decreasing IL-23-dependent IL-17 production.
16
 It has 
been reported that the R381Q allele confers protection 
against inflammatory bowel disease (IBD),
17
 
psoriasis,
18
 ankylosing spondylitis.
19
  
In this study, we evaluated the role of IL-23R 
R381Q polymorphism in susceptibility to asthma. 
Maybe this study can help to better understand the 
immunopathogenic process of asthma. 
 
MATERIALS AND METHODS 
 
Study Population 
This case-control study was performed on 209 
patients, and 200 healthy controls. The subjects studied 
were asthmatic patients attending the Allergy Clinic of 
the Amin hospital, Isfahan, Iran. A full verbal and 
written explanation of the study was given to all 
patients who had been interviewed before participation 
in this study. Informed consent was obtained and for 
subjects younger than 18 years old, it was given by 
their parents. The study was conformed to the 
provisions of the Declaration of Helsinki and approved 
by Isfahan University of Medical Sciences Ethics 
Committee.
20
 Asthma was diagnosed according to the 
criteria of the Global Initiative for Asthma (GINA).
21
 
Pregnancy or breast-feeding and presence of parasitic 
infection were exclusion criteria. The controls did not 
have any of the symptoms of allergic and respiratory 
disease in their previous history or past physical check-
up.  
 
Total Serum IgE Measurements 
Serum was separated from 4 ml blood samples, and 
total serum IgE estimation
 
was carried out for each 
subject using the Euroimmun IgE ELISA kit 
(Germany) according to the manufacturer’s 
instructions. 
 
Eosinophil Count 
For counting Eosinophils in the peripheral blood, a 
Cell Counter (SESMEX-XT 1800, Japan) was used. 
 
DNA Preparation 
Genomic DNA was extracted from peripheral blood 
cells using a Prime Prep
TM
 Genomic DNA isolation kit 
(Genet Bio, Korea) according to the manufacturer’s 
instructions. 
 
PCR- RFLP 
For PCR, the primers were designed by Primer3 
software. The sequence of the primer pairs was 5'-
CTTTTCTGGCAGGGTCATTTTG-3'(forward primer) 
and 5'-AAGTTGTTTCCTGGGGTAGTTGTG-
3'(reverse primer). The PCR conditions were optimized 
for R381Q SNP as follows: 95°C for 5 min; 30 cycles 
of 95°C for 30 s, 58°C for 30 s, and 72°C for 30 s; and 
a final extension at 72°C for 5 min. PCR amplification 
was carried out in a programmable PCR in an 
Eppendorf thermal cycler (Eppendorf, Germany). The 
508-bp PCR product was then resolved over a 1% 
agarose gel and the quality was confirmed using green 
viewer stain and a UV transilluminator. 
For RFLP assay, Hpy188i restriction endonuclease 
(New England Biolabs, Beverly, MA) was applied. The 
RFLP was performed in a total volume of 20 µl 
containing 10µl PCR product, 7.8µl distillated water, 
2µl related buffer and 0.2 µl restriction enzyme. The 
RFLP conditions were optimized in 37°c for 3 hours. 
The restriction-digested fragments were separated on 
2% agarose gels and stained with DNA green viewer 
and visualized under UV illumination. Hpy188i cut the 
508 bp PCR product into fragments 323, 288, 103, 82 
and 35 bp in sizes. Fragments of 288, 103, 82 and 35 
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bp indicated the presence of  homozygous GG 
genotype, and Fragments of 323, 288, 103 and 82 bp 
represented the presence of heterozygous GA genotype 
in Figure 1. 
 
Statistical Analysis 
The SPSS 20 software package (SPSS Company, 
Chicago, IL, USA) was used to carry out statistical 
analysis. Fisher exact test was first applied to compare 
the frequency distribution of gender, and smoking 
status between case and control groups. In addition, this 
test was used to compare the genotype distributions, 
allele frequencies between two groups of patients and 
controls. Association between this polymorphism and 
asthma was declared as odds ratios (OR) estimates with 
95% confidence intervals (95% CI). Logistic regression 
analysis was used to evaluate the association between 
the IL23R rs11209026 polymorphism and asthma. 
Furthermore, age, eosinophil count and total serum IgE 
levels between the two groups were compared by 
means of Independent T-Test and we also used analysis 
of covariance (ANCOVA) method to eliminate 
confounding factors. P-value <0.05 was considered 
significant in all of these tests. In order to have a 
normal distribution for the analysis, IgE levels were 
change to log10 values. 
 
 
RESULTS 
 
Selected features of the two groups and their 
relationship with asthma are shown in Table 1. As it is 
shown in Table1, the two variables, age and gender, 
were not significantly different between patients and 
controls. Compared to the controls, the cases had 
higher eosinophil counts and total serum IgE levels 
(p<0.001). In contrast smoking status was not 
statistically different between the two groups 
(p<0.726). 
In the present study, rs11209026 polymorphism of 
IL-23R in asthmatic patients and healthy controls from 
normal population were analyzed. Statistically 
significant differences were found in frequency of 
rs11209026 G>A polymorphism (numerical name of 
IL23R R381Q) between asthmatic patients and controls 
(p< 0.001, Crude Odds Ratio= 0.266, 95%, CI= 0.118-
0.604). 
In all studied groups, GG and GA genotypes were 
observed but AA genotype was not observed in any of 
the groups. A successful genotyping for the SNP in the 
all individuals was performed and verified by sequence 
analysis (reverse sequencing) of PCR products (Figure 
2 ). The genotype distribution in all of the subjects was 
in agreement with that expected by Hardy-Weinberg 
equilibrium.  
 
 
M            1               2            3              4                5              6 
 
Figure 1. Genotyping of the IL23R R381Q polymorphism by PCR-RFLP method in six unrelated subjects. Subject 1,2,3 and 
6 homozygote for the G allele; Subject 4 and 5 heterozygote for the A/G allele. M=marker 50bp 
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A) 
 
B) 
Figure 2- A) Electropherogram showing the location of the SNP as a double peak in the heterozygous condition for G/A genotype 
(arrow). B) Electropherogram showing the location of the SNP as a one peak in the homozygous condition for G/G genotype 
(arrow). The sequence that has been shown, is the reverse sequence, so instead of G, it is shown C & instead of A, it is shown T. 
 
The frequency of GA and GG genotypes in patients 
was 3.8 % and 96.2%, respectively and the frequency 
of A and G alleles were 1.9% and 98.1%, respectively.  
The multivariate logistic regression analysis was 
applied to investigate the association between the 
rs11209026 G>A polymorphism genotypes and 
asthma. As shown in Table 3, there is an association 
between GA genotype and asthma (adjusted OR= 
0.274, 95%, CI = 0.114-0.656, p=0.004, crude OR = 
0.266, 95%, CI = 0.118-0.604, p<0.001). 
 
Table 1. Frequency distributions of selected variables and characteristics of the study population in cases and controls 
 Case (N=209 ) control (N =200) P- value 
Age (mean±SD) 43.167±14.89 41.96±14.11 0.399 
Gender 
   male 
   female 
 
69(33%) 
140(67%) 
 
80(40%) 
120(60%) 
 
0.142 
 
Smoking 
   no 
   yes 
 
202(96.7%) 
7(3.3%) 
 
192(96%) 
8(4%) 
 
0.726 
 
Total serum IgE log10 (mean±SD) 1.73±0.65 0.75±0.38 0.001 
Eosinophils (mean±SD) 103 per µl 0.236 ±0.26 0.085±0.05 <0.001 
 
Table 2. Genotype and allele frequencies of IL23R rs11209026 G>A polymorphism 
Allel Control (N/%) Patients (N/%) CrudeOdds Ratio (95% CI) P-value 
A 26(6.5%) 8(1.9%) 0.266(0.118-0.604) <0.001 
G 374(93.5) 410(98.1) 3.56(1.59-7.97) <0.001 
Genotype     
GA 26(13%) 8(3.8%) 0.266(0.118-0.604) <0.001 
GG 174(87%) 201(96.2) 3.754(1.657-8.507) <0.001 
AA 0 (0%) 0 (0%)   
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Table 3. Adjusted Odds Ratios with 95% Confidence 
Interval (CI) in IL23R R381Q genotypes with adjustment for 
age, gender, smoke status, eosinophil count and total IgE. 
Groups adjusted Odds Ratios P-value 
GA 
GG 
0.274(0.114-0.656) 
3.651(1.523-8.749) 
0.004 
0.004 
 
DISCUSSION 
 
The previous studies have shown that population of 
Th17 cells are more frequent in circulation of asthmatic 
patients than in normal controls.
22
 In fact, relatively 
enriched levels of Th17 cells in circulation of asthmatic 
patients, suggest that these cells may play key roles in 
pathogenesis of asthma.
22
 IL-17, secreted by Th17 
cells, is suggested to have a major role in stimulating 
bronchial fibroblasts, epithelial cells, and smooth 
muscle cells and inducing the expression of a variety of 
cytokines and chemokines, which are important for 
granulopoiesis and neutrophil recruitment.
23
 IL-23 is 
crucial for the maintenance, differentiation, and 
effectors’ function of Th17 cells.12,24 The different 
genetic variants of the IL-23 receptor (IL-23R) have 
been studied in a number of inflammatory diseases.
25
  
Di Meglio et al showed that Th17 cells generated 
from A allele of IL23R R381Q had significantly 
reduced IL-23-induced IL-17A production compared to 
G allele.
25
 Considering that asthma is a common 
chronic inflammatory disease of the airways, in this 
study, the association between asthma and IL23R 
R381Q gene variant was shown. 
We undertook this study to determine the presence 
and prevalence of this gene mutation in asthma. In the 
present study, the frequency of the A allele in Iranian 
asthmatic patients and in normal controls was 1.9% and 
6.5%, respectively. 
Several studies have analyzed the A allele and 
various inflammatory diseases such as inflammatory 
bowel disease (IBD), crohn’s disease (CD), ulcerative 
colitis (UC),
26
 psoriasis,
27
 multiple sclerosis (MS) and 
ankylosing spondylitis (AS)
28
 in different populations. 
Richard H et al studied the frequency of IL23R 
R381Q gene variant in CD on a European non-Jewish 
population. Their results showed that frequency of CD 
patients having the A allele was 1.9% while it was 7% 
for controls.
26
 
P.L. Lakatos et al showed that the frequency of the 
A allele in UC patients was 2.68% while in controls it 
was 4.69%. Although, allele frequency in patients was 
lower than in control in their study, the difference did 
not reach significance (OR=0.56, 95% CI= 0.23-
1.35).
29
 Our result was consistent with these findings. 
In conclusion, although the allele frequencies of this 
polymorphism in different diseases and populations 
were different, all previous studies have supported 
protective role of R381Q polymorphism in IL-23R 
gene against inflammatory diseases. Therefore, we 
suggest functional analysis of R381Q polymorphism in 
IL-23R.    
Probable protective effect of R381Q polymorphism 
against asthma in Persian population may guide us 
towards interfering IL-23R functions as a potential 
therapeutic approach for asthmatic patients in future 
works.  
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